A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Recruiting now
Conditions studied: Relapsing Multiple Sclerosis
In brief
This is an observational, non-interventional, multicenter, open-label study in patients being treated with any approved injectable or selected oral DMT for RMS in Germany. Prospective, primary data will be collected via questionnaires and an electronic case report form (eCRF) over a period of up to four years. Additionally, medical history of participants will be collected including disease duration, laboratory values, EDSS, MRI parameters and relapses.
Key facts
- Study ID
- NCT05344469
- Run by
- Novartis Pharmaceuticals
- People needed
- 800
- Starts
- 2022-05-10
- Expected to finish
- 2029-05-30
- Last updated by the study team
- 2026-07-30
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Aalen, Germany (enrolling)
- Novartis Investigative Site — Berlin, Germany (enrolling)
- Novartis Investigative Site — Gelsenkirchen, North Rhine-Westphalia, Germany (enrolling)
- Novartis Investigative Site — Mühlhausen, Thuringia, Germany (enrolling)
- Novartis Investigative Site — Bergneustadt, Germany (enrolling)
- Novartis Investigative Site — Berlin, Germany (enrolling)
- Novartis Investigative Site — Dortmund, North Rhine-Westphalia, Germany (enrolling)
- Novartis Investigative Site — Düsseldorf, North Rhine-Westphalia, Germany (enrolling)
- Novartis Investigative Site — Dresden, Saxony, Germany (enrolling)
- Novartis Investigative Site — Jena, Thuringia, Germany (enrolling)
- Novartis Investigative Site — Altenholz, Germany (enrolling)
- Novartis Investigative Site — Hettingen, Baden-Wurttemberg, Germany (enrolling)
- Novartis Investigative Site — Schwetzingen, Baden-Wurttemberg, Germany (enrolling)
- Novartis Investigative Site — Untermeitingen, Bavaria, Germany (enrolling)
- Novartis Investigative Site — Mannheim, Baden-Wurttemberg, Germany (enrolling)
- Novartis Investigative Site — Dortmund, North Rhine-Westphalia, Germany (enrolling)
- Novartis Investigative Site — Bad Homburg, Hesse, Germany (enrolling)
- Novartis Investigative Site — Albstadt, Baden-Wurttemberg, Germany (enrolling)
- Novartis Investigative Site — Nagold, Baden-Wurttemberg, Germany (enrolling)
- Novartis Investigative Site — Meerbusch, North Rhine-Westphalia, Germany (enrolling)
- Novartis Investigative Site — Görlitz, Saxony, Germany (enrolling)
- Novartis Investigative Site — Halle, Saxony-Anhalt, Germany (enrolling)
- Novartis Investigative Site — Schwäbisch Hall, Baden-Wurttemberg, Germany (enrolling)
- Novartis Investigative Site — Cologne, North Rhine-Westphalia, Germany (enrolling)
- Novartis Investigative Site — Berlin, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.